Zdrowie i gospodarka · 27/11/2013
FDA Reopens Comment Period for Generic Drug User Fee Amendments Guidance
The Food and Drug Administration (FDA) is reopening the comment period for its draft guidance on Generic Drug User Fee Amendments of 2012, following technical difficulties that prevented some commenters from submitting comments online.
Source: Federal Register — Food and Drug AdministrationOpen original release →